Moreover, the YBX1 expression was observed in the nucleus of hepatocytes adjacent to adipose vacuoles in MASLD patients and mice but not in the control group, implying that high fat stimulation may facilitate the entry of YBX1 into the nucleus where it would function as a transcription factor (Figure 5A, B). Here, YBX1 is linked to metabolic dysfunction-associated steatotic liver disease.